1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. オペレーションタイプ別スニペット
3.3. エンドユーザー別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 高血圧の有病率の上昇
4.1.1.2. XX
4.1.2. 阻害要因
4.1.2.1. デバイスの高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. アームモニター
6.2.1. 序論
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. デジタルアームモニター
6.2.4. アネロイドアームモニター
6.2.5. マーキュリーアームモニター
6.3. リストモニター（デジタルリストモニター）
7. 操作タイプ別
7.1. はじめに
7.1.1. オペレーションタイプ別市場規模分析および前年比成長率分析（%） 7.1.2.
7.1.2. 市場魅力度指数（オペレーションタイプ別
7.2. 自動モニター
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 半自動モニター
7.4. 手動モニター
8. エンドユーザー別
8.1. はじめに
8.1.1. エンドユーザー別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院・専門クリニック
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 在宅ケアの設定
8.4. 外来手術センター（ASCs）
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.2.4. 市場規模分析とYoY成長率分析(%)、オペレーションタイプ別
9.2.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.2.6. 市場規模分析および前年比成長率分析(%)、国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.3.4. 市場規模分析およびYoY成長率分析(%)、オペレーションタイプ別
9.3.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.3.6. 市場規模分析および前年比成長率分析(%)、国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. スペイン
9.3.6.5. イタリア
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.4.4. 市場規模分析およびYoY成長率分析(%)、オペレーションタイプ別
9.4.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.4.6. 市場規模分析および前年比成長率分析(%)、国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.5.4. 市場規模分析とYoY成長率分析(%)、オペレーションタイプ別
9.5.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.5.6. 市場規模分析および前年比成長率分析(%)、国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.6.4. 市場規模分析およびYoY成長率分析（%）, オペレーションタイプ別
9.6.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Spacelabs Healthcare. *
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. BOSCH + SOHN GmbH Co. KG.
11.3. SunTech Medical, Inc.
11.4. Schiller AG
11.5. Baxter International Inc (Welch Allyn)
11.6. BPL Medical Technologies
11.7. A&D Company
11.8. Microlife Corporation
11.9. CONTEC MEDICAL SYSTEMS CO., LTD
11.10. Vaso Corporation
リストは網羅的ではありません
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ

Overview
The global Ambulatory blood pressure monitors market reached US$ 1.20 billion in 2023 and is expected to reach US$ 2.43 billion by 2031 growing with a CAGR of 9.2% during the forecast period 2024-2031.

Ambulatory blood pressure monitoring (ABPM) is a diagnostic method that measures a patient's blood pressure at regular intervals over 24 hours while they carry out their usual daily activities. This approach offers a more precise depiction of blood pressure variations compared to conventional office measurements, as it records fluctuations at different times throughout the day and night.
Ambulatory blood pressure monitoring (ABPM) devices consist of a portable monitor linked to a cuff worn on the arm or wrist, which automatically inflates at designated intervals to capture blood pressure readings Ambulatory blood pressure monitoring is a valuable and thorough method for assessing and managing hypertension. Delivering continuous, real-time data on blood pressure variations, improves diagnostic precision and enables healthcare providers to make well-informed treatment decisions, ultimately leading to better patient outcomes in managing hypertension.

Market Dynamics: Drivers
Rising prevalence of hypertension
The demand for the global ambulatory blood pressure monitors market is driven by multiple factors. The increasing prevalence of hypertension is a key factor propelling the ambulatory blood pressure monitoring (ABPM) market. With millions of individuals affected worldwide and an aging population at greater risk, there is an urgent demand for reliable blood pressure monitoring solutions. Advances in technology, rising health awareness, and supportive government programs further demand for the ABPM market.
Hypertension is a significant contributor to premature mortality globally. One of the international goals for noncommunicable diseases is to achieve a 33% reduction in the prevalence of hypertension between 2010 and 2030. As per WHO data in March 2023, an estimated 1.28 billion adults aged 30 to 79 years worldwide suffer from hypertension, with approximately two-thirds residing in low- and middle-income countries. About 46% of adults with hypertension are unaware of their condition, and less than half (42%) have been diagnosed and treated. Only 21% of those with hypertension manage to keep it under control.
Moreover, key players in the industry have technological advancements and product launches that would drive this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in October 2022, Biobeat is revolutionizing the 24-hour ambulatory blood pressure monitoring (ABPM) experience for both hypertension patients and healthcare providers through its innovative cuffless monitoring technology. This advancement addresses several limitations associated with traditional blood pressure monitoring methods.
Also, in May 2021, Biobeat, a prominent name in wearable remote patient monitoring technologies, has recently unveiled a new device specifically designed for continuous ambulatory blood pressure monitoring (ABPM) that can be worn comfortably on the chest. This advanced chest-monitoring device allows healthcare professionals to continuously track patients' blood pressure, significantly improving the ability to monitor vital signs outside conventional clinical environments.

Restraints
Factors such as the high costs of devices, limited reimbursement policies, and complications associated with use are expected to hamper the ambulatory blood pressure monitoring (ABPM) market.

Segment Analysis
The global ambulatory blood pressure monitors market is segmented based on product type, operation type, end-user, and region.
The arm monitors segment accounted for approximately 73.2% of the global ambulatory blood pressure monitors market share
The arm monitors segment is expected to hold the largest market share over the forecast period. Arm monitors are widely regarded as more accurate than wrist monitors for measuring blood pressure. They use a standard cuff that wraps around the upper arm, which is the recommended site for obtaining reliable readings. This level of accuracy makes them the preferred option for clinicians who need precise data for diagnosis and treatment.
Additionally, arm ambulatory blood pressure monitoring (ABPM) devices have been extensively utilized in clinical settings for many years. Their established presence in hospitals and clinics lends credibility to their use among healthcare professionals, leading to a continued preference for these devices over newer wrist models. Advancements in ambulatory blood pressure monitoring (ABPM) technology have greatly changed the field of blood pressure measurement, resulting in the creation of more compact and user-friendly devices, such as wrist and arm monitors.
Moreover, key players in the industry introduce innovative products and approvals that would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, one of the major players SunTech Medical launched the Oscar 2 ambulatory blood pressure monitor is esteemed as the leading device in 24-hour ambulatory blood pressure monitoring (ABPM).
It is designed to deliver essential diagnostic data that traditional in-clinic and home blood pressure monitors often miss, making it an invaluable resource for healthcare professionals. The device emphasizes patient comfort through its patented Orbit ABPM cuff, which is designed with a soft and flexible material that fits snugly around the arm. This design allows patients to wear the monitor for long durations without discomfort, encouraging greater compliance with monitoring protocols.
Similarly, The BPro EVO from HealthSTATS International is a third-generation ambulatory blood pressure monitor (ABPM) that integrates several advanced features aimed at improving patient monitoring and enhancing data accuracy.
Also, in October 2024, Huawei introduced the Watch D2 a smartwatch that sets itself apart with its sophisticated health monitoring features, particularly through its Ambulatory Blood Pressure Monitoring (ABPM) capability. This technology allows users to continuously monitor their blood pressure around the clock, providing critical insights into their cardiovascular health.

Geographical Analysis
North America accounted for approximately 43.2% of the global ambulatory blood pressure monitors market share
North America region is expected to hold the largest market share over the forecast period. The high prevalence of hypertension in North America significantly influences the ambulatory blood pressure monitors (ABPM) market. Hypertension, commonly referred to as high blood pressure, elevates the risk of heart disease and stroke, which are among the leading causes of death in the United States.
Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, government initiatives & regulatory support, technological advancements, & investments, and product launches would propel this ambulatory blood pressure monitoring (ABPM) market growth. For instance, in August 2022, CardiAI Inc. officially launched its new 24-hour ambulatory blood pressure monitoring system, named BPAro. This device is compact and portable, manufactured in Germany, and designed for individuals to monitor their blood pressure. Utilizing Bluetooth technology, BPAro wirelessly collects data, which is then securely uploaded to a cloud database for analysis.

Market Segmentation
By Product Type
• Arm Monitors
o Digital Arm Monitors
o Aneroid Arm Monitors
o Mercury Arm Monitors
• Wrist Monitors (Digital Wrist Monitors)
By Operation Type
• Automatic Monitors
• Semi-Automatic Monitors
• Manual Monitors
By End-User
• Hospitals & Specialty Clinics
• Homecare Settings
• Ambulatory Surgical Centers (ASCs)
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape
The major global players in the ambulatory blood pressure monitors market include Spacelabs Healthcare., BOSCH + SOHN GmbH Co. KG., SunTech Medical, Inc., Schiller AG, Baxter International Inc. (Welch Allyn, BPL Medical Technologies, A&D Company, Microlife Corporation, CONTEC MEDICAL SYSTEMS CO., LTD, and Vaso Corporation among others.

Key Developments
 In March 2024, seca Screen 300 ABPM was introduced as a state-of-the-art ambulatory blood pressure monitor (ABPM), recognized for its cutting-edge features and significant validation. It is distinguished as the first ABPM device in the world to achieve successful validation under the European Society of Hypertension International Protocol (ESH-IP) 2010 standards.

Why Purchase the Report?
• To visualize the global ambulatory blood pressure monitors market segmentation based on product type, operation type, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points on the ambulatory blood pressure monitors market in all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global ambulatory blood pressure monitors market report would provide approximately 62 tables, 51 figures, and 183 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Operation Type
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Hypertension
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Arm Monitors*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Digital Arm Monitors
6.2.4. Aneroid Arm Monitors
6.2.5. Mercury Arm Monitors
6.3. Wrist Monitors (Digital Wrist Monitors)
7. By Operation Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
7.1.2. Market Attractiveness Index, By Operation Type
7.2. Automatic Monitors *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automatic Monitors
7.4. Manual Monitors
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Specialty Clinics *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Homecare Settings
8.4. Ambulatory Surgical Centers (ASCs)
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Operation Type
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Spacelabs Healthcare. *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. BOSCH + SOHN GmbH Co. KG.
11.3. SunTech Medical, Inc.
11.4. Schiller AG
11.5. Baxter International Inc (Welch Allyn)
11.6. BPL Medical Technologies
11.7. A&D Company
11.8. Microlife Corporation
11.9. CONTEC MEDICAL SYSTEMS CO., LTD
11.10. Vaso Corporation
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us

※参考情報 外来血圧モニター（Ambulatory Blood Pressure Monitors）は、患者が日常生活を送る中で血圧を継続的に測定するための装置です。このモニターは通常、24時間から48時間の間隔で血圧を自動的に測定し、個人の血圧の変動を詳しく追跡できます。これにより、医師は血圧の異常を強く疑う必要がありますが、通常の診察時に測定された血圧とは異なり、より実状に近い情報を得ることができます。 外来血圧モニターの種類には、様々な形式があります。一般的には、上腕式と手首式の二つに大別されます。上腕式は、カフを上腕に巻きつけて測定するもので、通常の診療所で使用される血圧計に似ています。これに対して手首式は、手首に装着するタイプで、持ち運びが容易であるため、外出先でも手軽に使用できます。また、最近では、スマートフォンアプリと連携して血圧を管理できるデジタルデバイスも増えてきています。このようなデバイスは、血圧データを自動的にスマートフォンに転送し、グラフなどで視覚的に確認できるため、データ分析がしやすくなっています。 外来血圧モニターの主な用途は、特に高血圧やそのリスクがある患者の血圧を評価することです。通常の診察時には感じ取れない、日常生活でのストレスや活動による血圧の変動を把握するのに役立ちます。特に仮面高血圧と呼ばれる、診察時には血圧が正常でも、日常生活の中では高い状態になる患者に対しては、外来血圧モニターは非常に重要なツールです。これにより、正確な診断と適切な治療計画を立てることが可能になります。 また、外来血圧モニターは、睡眠時無呼吸症候群や高血圧の合併症を持つ患者のモニタリングにも利用されます。特に、夜間の血圧を測定することは、心血管疾患のリスク評価にとって重要です。さらに、治療の効果を評価するためにも役立ちます。たとえば、薬物治療を行っている場合、モニターが示すデータを基にしながら、医師は治療方針を修正したり、薬の投与量を調整したりします。 関連技術としては、リモートモニタリングや電子カルテとの連携が挙げられます。これにより、医師は患者のデータをリアルタイムで確認でき、適切なタイミングでの介入が可能となります。デジタル健康管理が進歩する中で、外来血圧モニターはますます重要な役割を果たすようになっています。また、血圧データは、人工知能を用いた解析によって、より精密な健康データの評価や予測が行えるようになってきています。 このように、外来血圧モニターは単なる測定器具だけでなく、患者の健康管理において多面的な役割を果たす重要な道具です。将来的には、さらなる技術革新により、より精度の高い、便利な血圧モニタリングが可能になることが期待されます。これにより、患者一人一人に対する個別化医療が進展し、より良い健康管理が実現されるでしょう。全国各地で外来血圧モニターの導入が進む中、医療機関と患者との連携が深まることで、心血管疾患を予防するための新たなアプローチが模索されていくことが望まれます。

*** 外来血圧モニターの世界市場に関するよくある質問(FAQ) ***

・外来血圧モニターの世界市場規模は？
→DataM Intelligence社は2023年の外来血圧モニターの世界市場規模を12億米ドルと推定しています。

・外来血圧モニターの世界市場予測は？
→DataM Intelligence社は2031年の外来血圧モニターの世界市場規模を24億3,000万米ドルと予測しています。

・外来血圧モニター市場の成長率は？
→DataM Intelligence社は外来血圧モニターの世界市場が2024年～2031年に年平均9.2%成長すると展望しています。

・世界の外来血圧モニター市場における主要プレイヤーは？
→「Spacelabs Healthcare.、BOSCH + SOHN GmbH Co. KG.、SunTech Medical, Inc.、Schiller AG、Baxter International Inc. Welch Allyn、BPL Medical Technologies、A&D Company、Microlife Corporation、CONTEC MEDICAL SYSTEMS CO., LTD、Vaso Corporationなど ...」を外来血圧モニター市場のグローバル主要プレイヤーとして判断しています。

※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/